Of America Corp /De/ Bank Acquires 670 Shares of HCA Healthcare, Inc. (NYSE:HCA) Stock

HCA Healthcare, Inc. (NYSE:HCAGet Free Report) major shareholder Of America Corp /De/ Bank purchased 670 shares of HCA Healthcare stock in a transaction dated Tuesday, July 26th. The shares were purchased at an average price of $27.97 per share, with a total value of $18,739.90. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Large shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.

HCA Healthcare Stock Down 0.0 %

Shares of HCA traded down $0.09 during mid-day trading on Friday, reaching $342.25. The company’s stock had a trading volume of 1,114,475 shares, compared to its average volume of 1,343,785. The company has a market cap of $84.26 billion, a price-to-earnings ratio of 15.58, a price-to-earnings-growth ratio of 1.10 and a beta of 1.68. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. The business has a fifty day moving average of $323.90 and a 200 day moving average of $341.86.

HCA Healthcare (NYSE:HCAGet Free Report) last posted its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter in the prior year, the business posted $5.90 EPS. As a group, analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be paid a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a yield of 0.84%. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend is Monday, March 17th. HCA Healthcare’s dividend payout ratio is presently 13.11%.

Institutional Investors Weigh In On HCA Healthcare

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Legacy Investment Solutions LLC bought a new position in shares of HCA Healthcare in the third quarter valued at about $39,000. Whipplewood Advisors LLC bought a new stake in shares of HCA Healthcare during the 4th quarter valued at $31,000. Tidemark LLC bought a new stake in HCA Healthcare during the fourth quarter worth about $36,000. Activest Wealth Management boosted its position in shares of HCA Healthcare by 1,250.0% during the 4th quarter. Activest Wealth Management now owns 135 shares of the company’s stock worth $40,000 after acquiring an additional 125 shares in the last quarter. Finally, Pinnacle Bancorp Inc. increased its stake in shares of HCA Healthcare by 50.0% in the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock valued at $45,000 after purchasing an additional 50 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research analysts recently issued reports on the stock. Bank of America decreased their price target on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating for the company in a research note on Monday, January 27th. KeyCorp decreased their price objective on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 7th. JPMorgan Chase & Co. reissued a “neutral” rating and set a $380.00 target price on shares of HCA Healthcare in a research note on Tuesday, December 17th. Royal Bank of Canada lowered their price target on shares of HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a research report on Monday, January 27th. Finally, Truist Financial reduced their target price on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $385.67.

Read Our Latest Stock Analysis on HCA

About HCA Healthcare

(Get Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Read More

Insider Buying and Selling by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.